The National Institutes of Health, through its Blueprint MedTech program, has established two incubator hubs and launched a funding solicitation in support of commercially viable, clinically focused neurotechnology solutions to diagnose and treat disorders of the nervous system.

NIBIB's Grace Peng provides an overview of the new NIH Bridge2AI program in an interview with Mimi Geerges. Source: Government Matters

NIBIB Intramural Research Program labs collaborate with other NIH researchers on tackle engineering challenges.

New computed tomography (CT) technology paired with artificial intelligence (AI)-based noise reduction offers superior detection of bone disease associated with multiple myeloma at lower radiation doses than conventional CT, according to a new study. Source: Science Daily/Radiological Society of North America

The use of rapid Covid tests has soared this year with the spread of omicron and free shipments organized by the Biden Administration. But in August the US Food and Drug Administration cautioned that people who get a negative result should still repeat the test a couple days later. That communication has led to a lot of confusion. Source: Bloomberg

A research team funded by the National Institutes of Health has shown that commercially available rapid antigen tests can detect past and present variants of concern and has identified potential mutations that may impact test performance in the future.

NIH announced it will provide funding to diagnostic test manufacturers for the development of the next generation of COVID-19 tests, with a focus on improved accessibility. Source: LabPulse 

NIH has issued two new funding opportunities for diagnostic test manufacturers to develop the next generation of COVID-19 diagnostics.

The NIH announced the winners of the DEBUT Challenge with prizes totaling $130,000